1264MO IMpower010: Exploratory analysis of disease-free survival (DFS) by TGFβ cancer-associated fibroblast (CAF) gene signature expression in patients (pts) with resected NSCLC treated with atezolizumab (atezo) or best supportive care (BSC)
| Autor: | Altorki, N.K., Reck, M., Wakelee, H., Felip, E., Vallieres, E., Liersch, R., Oizumi, S., Tanaka, H., Novello, S., McCune, S., Li, H., Molinero, L., Müller, S., Bennett, E., Gitlitz, B.J., McNally, V.A., Ballinger, M., Nabet, B., Srivastava, M.K., Zhou, C. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S732-S733 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|